干扰乙酰辅酶A合成酶2对三阴性乳腺癌MDA-MB-468细胞增殖及凋亡的影响

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1123 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Guide

Abstract Objective: To investigate the effect of acetyl-CoA synthase 2-（ACSS2） on proliferation and apoptosis in triple-negative breast cancer MDAMB468 cell and its potential mechanism. Methods:The mRNA and protein expression of ACSS2 in normal breast epithelial cells MCF-10A and human triplenegative breast cancer MDA-MB-468 cell was detected by quantitative real-time PCR（qRT-PCR） and Western blotting， respectively. SiRNAs specific for ACSS2（siRNA-ACSS2） or a scrambled sequence（siRNA-NC） were designed and synthesized as positive and negative controls for transfection, respectively. SiRNAACSS2 or siRNA-NC was transiently transfected into triplenegative breast cancer MDA-MB-468 cells. The interference efficiency of ACSS2 were assessed by qRT-PCR and Western blotting. The proliferation capacity of MDA-MB-468 before and after conducting the targeted interference with ACSS2 was examined by CCK-8 assay. The apoptosis rate of MDA-MB-468 cells before and after interference was determined, using flow cytometry. Additionally, PI3K/AKT signaling pathway and the apoptosis-related proteins such as cleaved-caspase-3, Bcl-2, Bax and proliferation marker ki-67 were detected by Western blotting. Results: Compared with normal breast epithelial cells MCF-10A, MDA-MB-468 cells were showed with higher levels of the mRNA and protein expression of ACSS2（P<0.01）. Compared with MDA-MB-468 cells without the interference, targeted interference of ACSS2 strongly inhibited its proliferation and remarkably induced the apoptosis in MDA-MB-468 cells（all P<0.01）. The protein expression levels of p-PI3K, p-Akt, Ki-67 and Bcl2 were significantly decreased （all P<0.01），meanwhile，the protein expression levels of cleaved-caspase-3 and Bax were marked increased （all P<0.01）.Conclusion: Interference with acetyl-CoA synthase 2 dramatically inhibit the proliferation of triple-negative breast cancer MDAMB468 cells and significantly promote the apoptosis of breast cancer cells, which may be through PI3K/AKT signaling pathway.

Key words：

Received: 15 December 2020

Fund:

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	FU Cong1
	ZHOU Yuepeng2
	YIN Chaoyun3
	LING Rui1
	PU Xi1
	TANG Xiang1
	CHEN Deyu1

Cite this article:

FU Cong1,ZHOU Yuepeng2,YIN Chaoyun3等.

#br# Effect of acetyl-CoA synthase 2 interference on the proliferation and apoptosis of human triple-negative breast cancer MDA-MB-468 cell lines

[J]. Journal of Jiangsu University(Medicine Edition), 2021, 31(05): 374-379.

URL:

http://zzs.ujs.edu.cn/xbyxb/EN/ OR http://zzs.ujs.edu.cn/xbyxb/EN/Y2021/V31/I05/374

［1］Shen M, Pan H, Chen Y, et al. A review of current progress in triplenegative breast cancer therapy［J］. Open Med （Wars）, 2020, 15（1）:1143-1149.

［2］Mediratta K, ElSahli S, D′Costa V, et al. Current progresses and challenges of immunotherapy in triplenegative breast cancer［J］. Cancers, 2020, 12（12）:E3529.

［3］Qattan A. Novel miRNA targets and therapies in the triplenegative breast cancer microenvironment: an emerging hope for a challenging disease［J］. Int J Mol Sci, 2020, 21（23）:8905.

［4］朱宇，胡格，凌锐，等. ACSS2上调参与食管鳞癌细胞缺氧诱导的放疗抵抗［J］.江苏大学学报（医学版），2017，27（3）:200-204.

［5］苏玉婷，凌锐，周月鹏，等. 敲低乙酰辅酶A合成酶短链家族成员2（ACSS2）抑制营养缺乏诱导的宫颈癌细胞迁移和侵袭及机制［J］. 细胞与分子免疫学杂志，2019, 35（10）: 926-931.

［6］Zhang S, He J, Jia Z, et al. AcetylCoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma［J］. Urol Oncol, 2018, 36（5）:243.e9-243.e20.

［7］蔡丽君，苏榕，李宁宁. 乙酰辅酶A合成酶2促进肿瘤转移作用的探讨［J］. 广州医科大学学报, 2018, 46（5）:97-100.

［8］糜磊，武丹，陶清，等. 乙酰辅酶A合成酶2低表达人胃癌细胞株MGC803的顺铂敏感性观察［J］. 山东医药，2019，59（18）:32-35.

［9］Yoshii Y, Furukawa T, Yoshii H, et al. Cytosolic acetylCoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetylCoA/acetate metabolism［J］. Cancer Sci, 2009, 100（5）: 821-827.

［10］Wang YH, Huang S, Zhu L, et al. Alternative transcription start site selection in ACSS2 controls its nuclear localization and promotes ribosome biosynthesis in hepatocellular carcinoma［J］. Biochem Biophys Res Commun, 2019, 514（3）:632-638.

［11］Elmore S. Apoptosis: a review of programmed cell death［J］. Toxicol Pathol, 2007, 35（4）:495-516.

［12］Song XF, Tian H, Zhang P, et al. Expression of cytcmediated mitochondrial apoptosisrelated proteins in rat renal proximal tubules during development［J］. Nephron, 2017, 135（1）:77-86.

［13］Yao H, Zhang X, Zhang N, et al. Wikstromol from wikstroemia indica induces apoptosis and suppresses migration of MDAMB231 cells via inhibiting PI3K/Akt pathway［J］. J Nat Med, 2021, 75（1）:178-185.

［14］Du C, Wang Y, Zhang Y, et al. LncRNA DLX6AS1 contributes to epithelialmesenchymal transition and cisplatin resistance in triplenegative breast cancer via modulating mir199b5p/paxillin axis［J］. Cell Transplant, 2020, 29:963689720929983.

［15］Lin Q, Ling YB, Chen JW, et al. Circular RNA circCDK13 suppresses cell proliferation, migration and invasion by modulating the JAK/STAT and PI3K/AKT pathways in liver cancer［J］. Int J Oncol, 2018, 53（1）:246-256.

［16］Wang S, Lei Y, Cai Z, et al. Girdin regulates the proliferation and apoptosis of pancreatic cancer cells via the PI3K/Akt signalling pathway［J］. Oncol Rep, 2018, 40（2）:599-608.

［17］Cao B, Liu C, Yang G. Downregulation of lncRNA ADAMTS9AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway［J］. Biomed Pharmacother, 2018, 11（107）:185-193.

［18］Yao H, Su S, Xia D, et al. Fbox and leucinerich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway［J］. Biomed Pharmacother, 2018, 11（107）:1712-1719.

［19］Niu L, Yang S, Zhao X, et al. Sericin inhibits MDAMB468 cell proliferation via the PI3K/Akt pathway in triplenegative breast cancer［J］. Mol Med Rep, 2021, 23（2）:140.

［20］Ni Y, Yang Y, Ran J, et al. MiR15a5p inhibits metastasis and lipid metabolism by suppressing histone acetylation in lung cancer［J］. Free Radic Biol Med, 2020, 12（161）: 150-162.